Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum CA-125 in relation to adnexal dysplasia and cancer in women at hereditary high risk of ovarian cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 Apr 2007

Hermsen Brenda B J, von Mensdorff-Pouilly Silvia, Berkhof Johannes, van Diest Paul J, Gille Johan J P, Menko Fred H, Blankenstein Marinus A, Kenemans Peter, Verheijen René H M

Abstract excerpt

PURPOSE: Serum CA-125 level is commonly used as indicator for ovarian cancer recurrence. However, its value for the prediction of neoplastic lesions is unknown. The aim of this study was to investigate whether CA-125 concentrations are indicative of adnexal dysplasia and cancer in women at heredi...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CA-125 Antigen
Share to Early Diagnosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Neoplasm Recurrence, Local

Share to Precancerous Conditions

Share to ROC Curve

Share to Statistics, Nonparametric

Source

Identifiers

PMID: 17416858
DOI: 10.1200/JCO.2006.06.7884

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17416858-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Serum CA-125 in relation to adnexal dysplasia and cancer in women at hereditary high risk of ovarian cancer.PMID 17416858Read ↗

Ovarian epithelial dysplasia and prophylactic oophorectomy for genetic risk.Semantic proximity Read ↗

Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations.Semantic proximity Read ↗

Risk of ovarian cancer in women with first-degree relatives with cancer.Semantic proximity Read ↗

CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer.Semantic proximity Read ↗

Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study.Semantic proximity Read ↗

Cancer antigen 125 level after a bilateral salpingo-oophorectomy: what is the contribution of the ovary to the cancer antigen 125 level?Semantic proximity Read ↗

Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer.Semantic proximity Read ↗

Comparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancer.Semantic proximity Read ↗

Use of CA-125 and ultrasound in high-risk women.Semantic proximity Read ↗

Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system.Semantic proximity Read ↗

[Ovarian epithelial dysplasia: Description of a dysplasia scoring scheme].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.